These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 31401115

  • 1. Clinical outcome of drug-coated balloon angioplasty in patients with femoropopliteal disease: A real-world single-center experience.
    AbuRahma AF, AbuRahma ZT, Scott G, Adams E, Beasley M, Davis M, Dean LS, Davis E.
    J Vasc Surg; 2019 Dec; 70(6):1950-1959. PubMed ID: 31401115
    [Abstract] [Full Text] [Related]

  • 2. Clinical Outcome of Drug-Eluted Stenting (Zilver PTX) in Patients With Femoropopliteal Occlusive Disease a Single Center Experience.
    AbuRahma AF, Beasley M, AbuRahma ZT, Davis M, Adams E, Dean LS, Shapiro J, Scott G, Davis E.
    J Endovasc Ther; 2022 Jun; 29(3):350-360. PubMed ID: 34622706
    [Abstract] [Full Text] [Related]

  • 3. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
    Reijnen MMPJ, van Wijck I, Zeller T, Micari A, Veroux P, Keirse K, Lee SW, Li P, Voulgaraki D, Holewijn S.
    J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
    [Abstract] [Full Text] [Related]

  • 4. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
    Scheinert D, Schmidt A, Zeller T, Müller-Hülsbeck S, Sixt S, Schröder H, Weiss N, Ketelsen D, Ricke J, Steiner S, Rosenfield K.
    J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
    [Abstract] [Full Text] [Related]

  • 5. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C, Lakhlifi E, Colacchio EC, Midy D, Bérard X, Poirier M, Ducasse E.
    J Vasc Surg; 2019 Sep; 70(3):981-995.e10. PubMed ID: 31126769
    [Abstract] [Full Text] [Related]

  • 6. The 24-Month Results of the Lutonix Global SFA Registry: Worldwide Experience With Lutonix Drug-Coated Balloon.
    Thieme M, Von Bilderling P, Paetzel C, Karnabatidis D, Perez Delgado J, Lichtenberg M, Lutonix Global SFA Registry Investigators.
    JACC Cardiovasc Interv; 2017 Aug 28; 10(16):1682-1690. PubMed ID: 28780030
    [Abstract] [Full Text] [Related]

  • 7. Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort.
    Torsello G, Stavroulakis K, Brodmann M, Micari A, Tepe G, Veroux P, Benko A, Choi D, Vermassen FEG, Jaff MR, Guo J, Dobranszki R, Zeller T, IN.PACT Global Investigators.
    J Endovasc Ther; 2020 Oct 28; 27(5):693-705. PubMed ID: 32583749
    [Abstract] [Full Text] [Related]

  • 8. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T, Rastan A, Macharzina R, Tepe G, Kaspar M, Chavarria J, Beschorner U, Schwarzwälder U, Schwarz T, Noory E.
    J Endovasc Ther; 2014 Jun 28; 21(3):359-68. PubMed ID: 24915582
    [Abstract] [Full Text] [Related]

  • 9. Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons.
    Phair J, Carnevale M, Lipsitz EC, Shariff S, Scher L, Garg K.
    Ann Vasc Surg; 2020 Jan 28; 62():8-14. PubMed ID: 31207400
    [Abstract] [Full Text] [Related]

  • 10. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent.
    Nguyen BN, Conrad MF, Guest JM, Hackney L, Patel VI, Kwolek CJ, Cambria RP.
    J Vasc Surg; 2011 Oct 28; 54(4):1051-1057.e1. PubMed ID: 21636240
    [Abstract] [Full Text] [Related]

  • 11. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF, Mezzetto L, Macrì M, Criscenti P, Corvasce A, Poli R.
    Ann Vasc Surg; 2018 Feb 28; 47():179-187. PubMed ID: 28943491
    [Abstract] [Full Text] [Related]

  • 12. Comparison of paclitaxel-coated balloon angioplasty with femoropopliteal bypass surgery in treating femoropopliteal lesions.
    Kavala AA, Kuserli Y, Turkyilmaz S.
    Vascular; 2021 Apr 28; 29(2):260-269. PubMed ID: 32838692
    [Abstract] [Full Text] [Related]

  • 13. Midterm Outcomes of Drug-Coated Balloon Angioplasty in Femoropopliteal Lesions in a Daily Practice Cohort.
    Nugteren M, Serné A, Verhoeven B, Koning O, van den Haak R, Scholtes V, Hinnen JW.
    Ann Vasc Surg; 2020 Apr 28; 64():188-197. PubMed ID: 31634609
    [Abstract] [Full Text] [Related]

  • 14. Drug-Coated Balloons for Complex Femoropopliteal Lesions: 2-Year Results of a Real-World Registry.
    Schmidt A, Piorkowski M, Görner H, Steiner S, Bausback Y, Scheinert S, Banning-Eichenseer U, Staab H, Branzan D, Varcoe RL, Scheinert D.
    JACC Cardiovasc Interv; 2016 Apr 11; 9(7):715-24. PubMed ID: 27056311
    [Abstract] [Full Text] [Related]

  • 15. 1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.
    Micari A, Vadalà G, Castriota F, Liso A, Grattoni C, Russo P, Marchese A, Pantaleo P, Roscitano G, Cesana BM, Cremonesi A.
    JACC Cardiovasc Interv; 2016 May 09; 9(9):950-6. PubMed ID: 27151609
    [Abstract] [Full Text] [Related]

  • 16. 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
    Steiner S, Willfort-Ehringer A, Sievert H, Geist V, Lichtenberg M, Del Giudice C, Sauguet A, Diaz-Cartelle J, Marx C, Ströbel A, Schult I, Scheinert D, RANGER SFA Investigators.
    JACC Cardiovasc Interv; 2018 May 28; 11(10):934-941. PubMed ID: 29730375
    [Abstract] [Full Text] [Related]

  • 17. 2-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.
    Micari A, Nerla R, Vadalà G, Castriota F, Grattoni C, Liso A, Russo P, Pantaleo P, Roscitano G, Cremonesi A.
    JACC Cardiovasc Interv; 2017 Apr 10; 10(7):728-734. PubMed ID: 28385412
    [Abstract] [Full Text] [Related]

  • 18. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
    Foley TR, Cotter RP, Kokkinidis DG, Nguyen DD, Waldo SW, Armstrong EJ.
    Catheter Cardiovasc Interv; 2017 May 10; 89(6):1078-1085. PubMed ID: 28295971
    [Abstract] [Full Text] [Related]

  • 19. Single-Center Experience With Lutonix Drug-Coated Balloons in Infrapopliteal Arteries.
    Steiner S, Schmidt A, Bausback Y, Bräunlich S, Ulrich M, Banning-Eichenseer U, Scheinert D.
    J Endovasc Ther; 2016 Jun 10; 23(3):417-23. PubMed ID: 27099285
    [Abstract] [Full Text] [Related]

  • 20. One-year outcomes of drug-coated balloon treatment for long femoropopliteal lesions: a multicentre cohort and real-world study.
    Yu X, Zhang X, Lai Z, Shao J, Zeng R, Ye W, Chen Y, Zhang B, Ma B, Cao W, Liu X, Yuan J, Zheng Y, Yang M, Ye Z, Liu B.
    BMC Cardiovasc Disord; 2021 Jul 03; 21(1):326. PubMed ID: 34217209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.